RZL-012

Also Known As:

5-(3,6-dibromo-9H-carbazol-9-yl)-N,N,N-trimethylpentan-1-aminium chloride

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Adiposis Dolorosa (Dercum's Disease) 01/01/2021 - "RZL-012, a New Fat Dissolving Molecule, Tested in Dercum's Disease Patients." 12/01/2021 - "RZL-012 (5-[3,6-dibromo-9H-carbazol-9-yl]-N,N,N-trimethylpentan-1-aminium chloride) is a novel investigational drug injected subcutaneously into fat tissues in patients with fat-related disorders (Dercum disease) or subjects seeking aesthetic changes. "